Stocktoria

CapsoVision, Inc CV

Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2025-07-02 · LEI

CapsoVision, Inc statistics & valuation

Market cap$375.7M
P / S27.7×
P / B28.3×
Net margin-186.8%
Return on equity-190.9%
FCF margin-169.4%
Return on capital-185.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-169.30% -186.80% 20242025
Gross margin (%)
54.20% 52.90% 20242025
Operating margin (%)
-169.40% -188.30% 20242025
Return on equity (%)
-190.90% 20242025
Shares outstanding
2.1M 46.9M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-118.40% -139.40% 20242025
Free cash flow margin (%)
-172.20% -169.40% 20242025
Debt / equity (×)
20242025
EPS ($)
-$9.85 -$1.03 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Gross margin52.9%54.2%
Operating margin-188.3%-169.4%
Net margin-186.8%-169.3%
FCF margin-169.4%-172.2%
Return on assets-139.4%-118.4%
Return on equity-190.9%15.4%
Current ratio3.778.24

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.